Establishing the proteome of normal human cerebrospinal fluid

Steven E Schutzer, Tao Liu, Benjamin H Natelson, Thomas E Angel, Athena A Schepmoes, Samuel O Purvine, Kim K Hixson, Mary S Lipton, David G Camp, Patricia K Coyle, Richard D Smith, Jonas Bergquist, Steven E Schutzer, Tao Liu, Benjamin H Natelson, Thomas E Angel, Athena A Schepmoes, Samuel O Purvine, Kim K Hixson, Mary S Lipton, David G Camp, Patricia K Coyle, Richard D Smith, Jonas Bergquist

Abstract

Background: Knowledge of the entire protein content, the proteome, of normal human cerebrospinal fluid (CSF) would enable insights into neurologic and psychiatric disorders. Until now technologic hurdles and access to true normal samples hindered attaining this goal.

Methods and principal findings: We applied immunoaffinity separation and high sensitivity and resolution liquid chromatography-mass spectrometry to examine CSF from healthy normal individuals. 2630 proteins in CSF from normal subjects were identified, of which 56% were CSF-specific, not found in the much larger set of 3654 proteins we have identified in plasma. We also examined CSF from groups of subjects previously examined by others as surrogates for normals where neurologic symptoms warranted a lumbar puncture but where clinical laboratory were reported as normal. We found statistically significant differences between their CSF proteins and our non-neurological normals. We also examined CSF from 10 volunteer subjects who had lumbar punctures at least 4 weeks apart and found that there was little variability in CSF proteins in an individual as compared to subject to subject.

Conclusions: Our results represent the most comprehensive characterization of true normal CSF to date. This normal CSF proteome establishes a comparative standard and basis for investigations into a variety of diseases with neurological and psychiatric features.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Venn diagram showing the amount…
Figure 1. Venn diagram showing the amount of overlap of our dataset with a comparable dataset of proteins detected in the CSF of “normal clinical value” or “neurologic surrogate-normal” individuals who required a lumbar puncture for clinical reasons as reported by Zougman et al.
The large circle represents the 2630 proteins observed in our comprehensive dataset of proteins detected in the CSF of normal individuals. The small circle represents the 798 proteins identified in the analysis by Zougman et al.
Figure 2. Unsupervised hierarchical clustering of all…
Figure 2. Unsupervised hierarchical clustering of all proteins identified and quantified in direct LC-MS analyses of CSF samples from 10 normal healthy individuals (5 males and 5 females; 37–44 years old; each has two longitudinal samples collected at least 4 weeks apart).
Log2 transformed protein abundances were used. M: male; F: female; numbers right after the hyphen indicate the two serial samples from the same individual.
Figure 3. Unsupervised hierarchical clustering of all…
Figure 3. Unsupervised hierarchical clustering of all proteins identified and quantified in direct replicate LC-MS analyses of pooled CSF from non-neurologic surrogate-normal individuals (n = 200) and neurologic surrogate-normal (headache) patients (n = 10).
Log2 transformed protein abundances were used.

References

    1. Ransohoff RM. Immunology: Barrier to electrical storms. Nature. 2009;457:155–156.
    1. Ekegren T, Hanrieder J, Bergquist J. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience-Exemplified in amyotrophic lateral sclerosis biomarker discovery research. J Mass Spectrom. 2008;43:559–571.
    1. Rozek W, Ricardo-Dukelow M, Holloway S, Gendelman HE, Wojna V, et al. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J Proteome Res. 2007;6:4189–4199.
    1. Sickmann A, Dormeyer W, Wortelkamp S, Woitalla D, Kuhn W, et al. Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 2000;21:2721–2728.
    1. Yuan X, Desiderio DM. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid. Proteomics. 2005;5:541–550.
    1. Wenner BR, Lovell MA, Lynn BC. Proteomic analysis of human ventricular cerebrospinal fluid from neurologically normal, elderly subjects using two-dimensional LC-MS/MS. J Proteome Res. 2004;3:97–103.
    1. Maccarrone G, Milfay D, Birg I, Rosenhagen M, Holsboer F, et al. Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry. Electrophoresis. 2004;25:2402–2412.
    1. Zougman A, Pilch B, Podtelejnikov A, Kiehntopf M, Schnabel C, et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome. J Proteome Res. 2008;7:386–399.
    1. Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, et al. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol Aging. 2005;26:207–227.
    1. Xu J, Chen J, Peskind ER, Jin J, Eng J, et al. Characterization of proteome of human cerebrospinal fluid. Int Rev Neurobiol. 2006;73:29–98.
    1. Pan S, Zhu D, Quinn JF, Peskind ER, Montine TJ, et al. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics. 2007;7:469–473.
    1. Qian WJ, Liu T, Petyuk VA, Gritsenko MA, Petritis BO, et al. Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled “universal” reference sample. J Proteome Res. 2009;8:290–299.
    1. Petyuk VA, Qian WJ, Chin MH, Wang H, Livesay EA, et al. Spatial mapping of protein abundances in the mouse brain by voxelation integrated with high-throughput liquid chromatography-mass spectrometry. Genome Res. 2007;17:328–336.
    1. Ramstrom M, Hagman C, Mitchell JK, Derrick PJ, Hakansson P, et al. Depletion of high-abundant proteins in body fluids prior to liquid chromatography fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res. 2005;4:410–416.
    1. Shaffer SA, Tang KQ, Anderson GA, Prior DC, Udseth HR, et al. A novel ion funnel for focusing ions at elevated pressure using electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 1997;11:1813–1817.
    1. Smith RD, Anderson GA, Lipton MS, Pasa-Tolic L, Shen Y, et al. An accurate mass tag strategy for quantitative and high-throughput proteome measurements. Proteomics. 2002;2:513–523.
    1. Lipton MS, Pasa-Tolic' L, Anderson GA, Anderson DJ, Auberry DL, et al. Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags. Proc Natl Acad Sci U S A. 2002;99:11049–11054.
    1. Qian WJ, Monroe ME, Liu T, Jacobs JM, Anderson GA, et al. Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics. 2005;4:700–709.
    1. Bergquist J, Palmblad M, Wetterhall M, Hakansson P, Markides KE. Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Mass Spectrom Rev. 2002;21:2–15.
    1. Liu T, Qian WJ, Mottaz HM, Gritsenko MA, Norbeck AD, et al. Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol Cell Proteomics. 2006;5:2167–2174.
    1. Liu T, Qian WJ, Gritsenko MA, Xiao W, Moldawer LL, et al. High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics. 2006;5:1899–1913.
    1. Mayampurath AM, Jaitly N, Purvine SO, Monroe ME, Auberry KJ, et al. DeconMSn: a software tool for accurate parent ion monoisotopic mass determination for tandem mass spectra. Bioinformatics. 2008;24:1021–1023.
    1. Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res. 2003;2:43–50.
    1. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods. 2007;4:207–214.
    1. Qian WJ, Liu T, Monroe ME, Strittmatter EF, Jacobs JM, et al. Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. J Proteome Res. 2005;4:53–62.
    1. Zubarev R, Mann M. On the proper use of mass accuracy in proteomics. Mol Cell Proteomics. 2007;6:377–381.
    1. Monroe ME, Tolic N, Jaitly N, Shaw JL, Adkins JN, et al. VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Bioinformatics. 2007;23:2021–2023.
    1. Zimmer JS, Monroe ME, Qian WJ, Smith RD. Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom Rev. 2006;25:450–482.
    1. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 2003;75:4646–4658.
    1. Polpitiya AD, Qian WJ, Jaitly N, Petyuk VA, Adkins JN, et al. DAnTE: a statistical tool for quantitative analysis of -omics data. Bioinformatics. 2008;24:1556–1558.
    1. Bhatia VN, Perlman DH, Costello CE, McComb ME. Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Anal Chem. 2009;81:9819–9823.
    1. Yuan X, Russell T, Wood G, Desiderio DM. Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis. 2002;23:1185–1196.

Source: PubMed

Подписаться